Colorectal Lesion Evaluation and Appropriate Resolution (CLEAR) Study

Part of paid clinical trials in Kansas City, Missouri.

Sponsor
Harbinger Health
Study ID
NCT07479381
Status
Terminated

Conditions

  • Colorectal Cancer (Diagnosis)

Eligibility Criteria

Sex
ALL
Age
45 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The primary objective of this study is to evaluate a blood-based screening test for Colorectal Cancer (CRC).

Key Dates

Start date
Mar 20, 2026
Status verified
Apr 2026
Primary completion
Mar 27, 2026
Completion
Mar 27, 2026

Study Design

Enrollment
14 participants (actual)

Arms

  • Arm: Cohort 1: Prospective Cohort
    Participants with average risk CRC and a positive mt-sDNA test within 12 months of the study blood draw and who are scheduled and intending to undergo a diagnostic colonoscopy within 60 days of consent as part of standard care.
  • Arm: Cohort 2: Confirmed Case Cohort
    Participants with a confirmed colorectal cancer diagnosis at informed consent and who are treatment-naïve for the current malignancy.

Primary Outcome Measure

Establish predictive value [ Time Frame: 14 month ]

Locations (1)

FacilityCityStateZIPSite coordinators
Aton HealthKansas CityMissouri64114-

Find similar trials in Kansas City, MO

By research site
Aton Health· Kansas City, MO

Related Studies